I agree with Albie here. MEMs strategy to penetrate the market, given the technology is new and drastically different to what has been done for male fertility, is to leverage leaders in the field around the globe to market the product. It wouldn't make sense to both leverage industry leaders to market and then go to smaller distributors to try sell them the product. For the medical arena, which traditionally have err on the side of caution, this strategy would be more viable than a cold calling sales strategy.
Ann: Upgraded Felix Device verification passed, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 841570 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 700000 | 1 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable